Plexus (NASDAQ:PLXS) Receives Buy Rating from Benchmark

Plexus (NASDAQ:PLXS)‘s stock had its “buy” rating reissued by equities researchers at Benchmark in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $220.00 price objective on the technology company’s stock. Benchmark’s target price suggests a potential upside of 11.25% from the company’s previous close.

Several other research analysts have also recently issued reports on the company. Williams Trading set a $195.00 price objective on Plexus in a research report on Wednesday, January 28th. Wall Street Zen lowered shares of Plexus from a “buy” rating to a “hold” rating in a research report on Sunday, March 8th. Needham & Company LLC upped their price target on shares of Plexus from $165.00 to $206.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Stifel Nicolaus increased their price target on shares of Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a report on Friday, January 30th. Finally, Zacks Research upgraded shares of Plexus from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $194.20.

Plexus Stock Performance

PLXS traded up $7.00 during trading on Monday, reaching $197.74. The company’s stock had a trading volume of 74,273 shares, compared to its average volume of 335,359. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59. The company’s fifty day moving average price is $188.27 and its 200-day moving average price is $160.20. Plexus has a 52-week low of $103.43 and a 52-week high of $211.84. The company has a market capitalization of $5.30 billion, a price-to-earnings ratio of 30.64 and a beta of 0.81.

Plexus (NASDAQ:PLXS) last issued its earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. The business had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.07 billion. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The company’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.73 EPS. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. On average, equities analysts forecast that Plexus will post 5.9 earnings per share for the current fiscal year.

Insider Buying and Selling at Plexus

In other Plexus news, CEO Todd P. Kelsey sold 8,120 shares of the stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $205.65, for a total transaction of $1,669,878.00. Following the sale, the chief executive officer owned 78,598 shares in the company, valued at approximately $16,163,678.70. This represents a 9.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Angelo Michael Ninivaggi, Jr. sold 4,303 shares of the firm’s stock in a transaction on Thursday, February 5th. The stock was sold at an average price of $203.06, for a total value of $873,767.18. Following the transaction, the chief accounting officer directly owned 20,099 shares of the company’s stock, valued at $4,081,302.94. The trade was a 17.63% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 47,995 shares of company stock worth $9,718,476. 1.78% of the stock is currently owned by insiders.

Institutional Trading of Plexus

A number of large investors have recently made changes to their positions in PLXS. Corient Private Wealth LLC raised its stake in Plexus by 6.1% in the 4th quarter. Corient Private Wealth LLC now owns 1,929 shares of the technology company’s stock valued at $284,000 after purchasing an additional 111 shares during the last quarter. Caitlin John LLC acquired a new stake in shares of Plexus during the 4th quarter worth about $408,000. Fuller & Thaler Asset Management Inc. boosted its stake in shares of Plexus by 5.8% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 446,705 shares of the technology company’s stock worth $65,666,000 after purchasing an additional 24,441 shares during the last quarter. XTX Topco Ltd purchased a new stake in shares of Plexus during the fourth quarter worth about $758,000. Finally, Palisade Capital Management LP purchased a new stake in shares of Plexus during the fourth quarter worth about $2,003,000. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.